Use of a commercial consumer panel to recruit a comparator cohort for a pharmacoepidemiologic study

Pharmacoepidemiology and Drug Safety

Volumn 5, Issue 3, 1996, Pages 165-172

  Gardner, Jacqueline S ^a   Szpunar, Cheryl A ^b   O'Connell, Martin J ^b   Facklam, David P ^c   Mariano, Joseph P ^d   Borden, E Keith ^d   Leinweber, Frank B ^e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PFIZER INC   (United States)

^c ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

^d NFO Research Inc ^*

^e NFO Research Inc   (United States)

Author keywords

Cohort studies; Epidemiologic methods; Pharmacoepidemiology; Postmarketing surveillance; Prescription drugs

Indexed keywords

MINOXIDIL;

ARTICLE; COHORT ANALYSIS; COST; DRUG SURVEILLANCE PROGRAM; HUMAN; INFORMATION PROCESSING; METHODOLOGY; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; RESEARCH;

EID: 0029937133     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199605)5:3<165::AID-PDS197>3.0.CO;2-9     Document Type: Article

References (25)

1. Richard, B. W., Melville, A. and Lasagna, L. Postapproval research as a condition of approval: An update, 1985-1986. Journal of Clinical Research and Drug Development 1989; 3: 247-257.
2. Mattison, N. and Richard, B. W. Research requested by the FDA at the time of NCE approval, 1970-1984. Drug Information Journal 1987; 21: 309-329.
3. Kosman, M. E. Evaluation of a new antihypertensive agent Minoxidil. Journal of the American Medical Association 1980; 244: 73-75.
4. Johnson, B. F., Black, H. R., Beckner, R., et al. A comparison of minoxidil and hydralazine in nonazotemic hypertensives. Journal of Hypertension 1983; 1: 103-107.
5. Houston, M. C., McChesney, J. A. and Chatterjee, K. Pericardial effusion associated with minoxidil therapy. Archives of Internal Medicine 1981; 141: 69-71.
6. Herrera, C. R. and Lynch, C. Is baldness a risk factor for coronary artery disease? A review of the literature. Journal of Clinical Epidemiology 1990; 43: 1255-1260.
7. Lesko, S. M., Rosenberg, L. and Shapiro, S. A case-control study of baldness in relation to myocardial infarction in men. Journal of the American Medical Association 1993; 269: 998-1003.
8. Persson, B. and Johansson, B. W. The Kockum study: Twenty-two-year follow-up. Acta Medica Scandinavica 1984; 216: 485-493.
9. Trevisan, M., Jossa, F., Krogh, V., et al. Baldness and coronary heart disease risk factors. Circulation 1990; 81: 18.
10. Emidy, L., Xhang, H., Stamler J., et al. Does the state of your pate relate to your fate? Presentation to the 27th Annual Conference on Cardiovascular Disease Epidemiology. Charleston, SC: March 19-21, 1987.
11. Rawson, N. S. and Inman, W. H. Prescription-Event Monitoring. Recent experience with 5 NSAIDs. Medical Toxicology 1986; 1 Suppl 1: 79-82.
12. Baker, M. I. and Oleen, M. A. The use of benzodiazepine hypnotics among the elderly. Pharmacotherapy 1988; 8: 241-247.
13. Borden, E. K. and Lee, J. G. A methodologic study of post-marketing drug evaluation using a pharmacy-based approach. Journal of Chronic Diseases 1982; 35: 803-816.
14. Facklam, D. P., Gardner, J. S., Neidert, G. L. and Westland, M. M. An epidemiologic postmarketing surveillance stud of prescription acne medications. American Hournal of Public Health 1990; 80: 50-53.
15. Greenland, S. Response and follow-up bias in cohort studies. American Journal of Epidemiology 1977; 106: 184-187.
16. Churchill, G. A. Jr. Marketing Research: Methodological Foundations, 3rd edn. The Dryden Press, Chicago, 1983.
17. Bailar, B. A. Information needs, surveys and measurement errors. In: Panel Surveys. Kasprzyk, D., Duncan, G. J, Kalton, G. and Singh, M. P. (Eds) John Wiley and Sons, New York, 1989.
18. Sudman, S. and Ferber, R. Consumer Panels. American Marketing Association, Chicago, 1979.
19. Gillum, R. F. and Feinleib, M. Cardiovascular disease in the United States: Mortality, prevalence, and incidence. In: Prognosis and Risk Assessment in Cardiovascular Disease. Kapoor, A. S. and Singh, B. N. (Eds) Churchill Livingstone Inc., New York, 1993.
20. Makuc, D. M, Feldman, J. J. and Gillum, R. F. Educational differentials in heart disease incidence and case-fatality rates in a national sample. American Journal of Epidemiology 1988; 128: 892.
21. Cook, E. F. and Goldman, L. Performance of tests of significance based on stratification by a multivariate confounder score or by a propensity score. Journal of Clinical Epidemiology 1989; 42: 317-324.
22. 2 agonists: an example of the channeling phenomenon. Post Marketing Surveillance 1991; 5: 57-66.
23. Harlow, B. L. and Davis, S. Two one-step methods for household screening and interviewing using random digit dialing. American Journal of Epidemiology 1988; 127: 857-863.
24. Greenberg, E. R. Random digit dialing for control selection: a review and a caution on its uses in studies of childhood cancer. American Journal of Epidemiology 1990; 131: 1-5.
25. Stampfer, M. J., Willett, W. C., Speizer, F. E., et al. Test of the National Death Index. American Journal of Epidemiology 1984; 119: 837-839.